Profile

Company Profile

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch has received regulatory authorization to market AC5® Advanced Wound System and AC5® Topical Hemostat as medical devices in the United States and Europe, respectively. Arch's development stage product candidates include AC5-G™, AC5-V® and AC5® Surgical Hemostat, among others.1,2

1. AC5-G, AC5-V, and AC5 Surgical Hemostat are currently investigational devices limited by law to investigational use.
2. AC5, AC5-G, AC5-V and associated logos are trademarks and/or registered trademarks of Arch Therapeutics, Inc. and/or its subsidiaries.

Company Info

Address:
235 Walnut Street
Suite 6
Framingham, MA 01702 US

Telephone:
855-340-2784

Email:
investors@archtherapeutics.com

Industry Classifications

Sector:
Industrials

Industry:
Conglomerates

NAICS:
Offices of Other Holding Companies (551112)

SIC:
Offices Of Holding Companies, Not Elsewhere Classified (6719)